U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H21NO4
Molecular Weight 327.3743
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BOLDINE

SMILES

[H][C@]12CC3=CC(O)=C(OC)C=C3C4=C1C(CCN2C)=CC(O)=C4OC

InChI

InChIKey=LZJRNLRASBVRRX-ZDUSSCGKSA-N
InChI=1S/C19H21NO4/c1-20-5-4-10-7-15(22)19(24-3)18-12-9-16(23-2)14(21)8-11(12)6-13(20)17(10)18/h7-9,13,21-22H,4-6H2,1-3H3/t13-/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H21NO4
Molecular Weight 327.3743
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Boldine, an aporphine alkaloid, found abundantly in the leaves/bark of boldo (Peumus boldus Molina) widely consumed in the folk medicine of some regions. Boldine possesses various pharmacological properties including, anticancer activity. It exhibits a significant improvement of learning and memory through inhibition of brain acetylcholinesterase activity and alleviation of brain oxidative stress, which was shown on animal models. Boldine is a potentially useful agent for the treatment of leishmaniosis. In addition, it suppresses osteoclastogenesis, improves bone destruction and may be a potential therapeutic agent for rheumatoid arthritis. Besides, was shown, that boldine inhibits telomerase in cells treated with sub-cytotoxic concentrations. Telomerase inhibition occurs via down-regulation of human telomerase reverse transcriptase (hTERT), the catalytic subunit of the enzyme.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P22303|||Q53F46
Gene ID: 43.0
Gene Symbol: ACHE
Target Organism: Homo sapiens (Human)
Target ID: O14746
Gene ID: 7015.0
Gene Symbol: TERT
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Screening for new compounds with antiherpes activity.
1984 Oct
Antipoliovirus structure-activity relationships of some aporphine alkaloids.
1998 Apr
Halogenated boldine derivatives with enhanced monoamine receptor selectivity.
2000 Apr
Protective effect of boldine on dopamine-induced membrane permeability transition in brain mitochondria and viability loss in PC12 cells.
2002 Feb 1
Free-radical scavengers and antioxidants from Peumus boldus Mol. ("Boldo").
2003 Apr
Spectroscopic study of antileishmanial drug incubated in the promastigotes of Leishmania mexicana.
2003 Nov
A novel alkaloid antioxidant, Boldine and synthetic antioxidant, reduced form of RU486, inhibit the oxidation of LDL in-vitro and atherosclerosis in vivo in LDLR(-/-) mice.
2004 Apr
[Alkaloids from the root of Lindera angustifolia].
2005 Oct
Boldine and its antioxidant or health-promoting properties.
2006 Jan 5
Are extraction methods in quantitative assays of pharmacopoeia monographs exhaustive? A comparison with pressurized liquid extraction.
2006 Oct
Simultaneous determination of four alkaloids in Lindera aggregata by ultra-high-pressure liquid chromatography-tandem mass spectrometry.
2008 Nov 28
Boldine: a potential new antiproliferative drug against glioma cell lines.
2009 Dec
5-Hydroxytryptamine2A receptor binding activity of compounds from Litsea sessilis.
2009 Mar
Grandine A, a new proaporphine alkaloid from the bark of Phoebe grandis.
2009 Mar 23
Direct identification of phenolic constituents in Boldo Folium (Peumus boldus Mol.) infusions by high-performance liquid chromatography with diode array detection and electrospray ionization tandem mass spectrometry.
2010 Jan 22
Current and developing therapeutic agents in the treatment of Chagas disease.
2010 Sep 24
Boldine, a natural aporphine alkaloid, inhibits telomerase at non-toxic concentrations.
2015 Apr 25
Boldine enhances bile production in rats via osmotic and farnesoid X receptor dependent mechanisms.
2015 May 15

Sample Use Guides

in mice: boldine (1.5, 3 and 6mg/kg, po) for 7 successive days exhibited significant improvement of learning and memory of young and aged mice anticonvulsant effects in mice: boldine (once in a day for 8 days, ip.) in mice: repeated i. p. injections of 30, 60, or 90 mg boldine/kg slowed tumor growth
Route of Administration: Other
It was shown that boldine is a potentially useful agent for the treatment of leishmaniasis. The in vitro system consisted of murine macrophage infection with amastigotes of L. amazonensis treated with different concentrations from 50 to 600 μg/ml of boldine for 24 hr. Intracellular parasite destruction was assessed by morphological examination and boldine cytotoxicity to macrophages was tested by the MTT viability assay. When cells were treated with 100 μg/ml of boldine the reduction of parasite infection was 81% compared with untreated cultures cells.
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:36:57 GMT 2023
Edited
by admin
on Fri Dec 15 18:36:57 GMT 2023
Record UNII
8I91GE2769
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BOLDINE
MI   WHO-DD  
Common Name English
(6AS)-5,6,6A,7-TETRAHYDRO-1,10-DIMETHOXY-6-METHYL-4H-DIBENZO(DE,G)QUINOLINE-2,9-DIOL
Common Name English
BOLDINE [MI]
Common Name English
1,10-DIMETHOXY-2,9-DIHYDROXYAPORPHINE
Systematic Name English
Boldine [WHO-DD]
Common Name English
1,10-DIMETHOXY-6A.ALPHA.-APORPHINE-2,9-DIOL
Common Name English
(S)-BOLDINE
Common Name English
2,6-DIHYDROXY-3,5-DIMETHOXYAPORPHINE
Common Name English
NSC-65689
Code English
BOLDINE [EP MONOGRAPH]
Common Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/13/1226
Created by admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID40883394
Created by admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
PRIMARY
ECHA (EC/EINECS)
207-509-9
Created by admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
PRIMARY
EVMPD
SUB13107MIG
Created by admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
PRIMARY
PUBCHEM
10154
Created by admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
PRIMARY
NSC
65689
Created by admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
PRIMARY
SMS_ID
100000076875
Created by admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
PRIMARY
FDA UNII
8I91GE2769
Created by admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
PRIMARY
WIKIPEDIA
BOLDINE
Created by admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
PRIMARY
MERCK INDEX
m2598
Created by admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
PRIMARY Merck Index
CAS
476-70-0
Created by admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
PRIMARY
MESH
C011686
Created by admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT